跳到正文

ProKidney Corp. 提交8-K,披露签订重大最终协议

SEC EDGAR 8-K·(美东 10月29日 17:15)· 3 天前

8-K - PROKIDNEY CORP. (0001850270) (Filer)

AI 导读

据SEC EDGAR 8-K文件,ProKidney Corp.(CIK 0001850270)于2026年10月29日提交并获接受的8-K报告涵盖报告期2026年10月29日,列明第1.01项“签订重大最终协议”和第9.01项“财务报表与附件”。文件共11份,包含8-K主文档及XBRL分类扩展等数据文件。

报错 · 内容有误?请告诉我们。

正文 · 原文

Filing Date

2026-10-29

Accepted

2026-10-29 17:15:45

Documents

11

Period of Report

2026-10-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d145896d8k.htm   iXBRL 8-K 30521
  Complete submission text file 0001193125-26-438071.txt   150577

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prok-20261029.xsd EX-101.SCH 3184
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prok-20261029_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prok-20261029_pre.xml EX-101.PRE 11710
14 EXTRACTED XBRL INSTANCE DOCUMENT d145896d8k_htm.xml XML 3782

Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103

Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028

PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 261502888
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

来源:SEC EDGAR 8-K · sec.gov